Roraima investiga caso suspeito de poliomielite em adolescente

In late August, health officials in Rorainópolis, a small municipality in Brazil's Roraima state, received word of a fourteen-year-old girl hospitalized with acute flaccid paralysis. The case arrived as a shock to a country that had not seen poliomyelitis in thirty-three years. The girl had received seven doses of the oral polio vaccine—a fact that made the diagnosis all the more unsettling. She was transferred to a hospital in Boa Vista, the state capital, where epidemiologists began the work of determining whether the paralysis was indeed caused by the poliovirus, a pathogen Brazil had successfully eliminated since 1989.

The timing of the case exposed a vulnerability that public health experts had been warning about for months. Across Brazil, vaccination rates against polio had collapsed. By late August, as a national vaccination campaign entered its final weeks, approximately eleven million children had not received the vaccine. That represented only 22.1 percent of the target population—a staggering shortfall for a disease that once crippled thousands. The municipal health office in Rorainópolis issued a stark statement: despite polio's official eradication status, the sharp decline in vaccination coverage made the virus's return not merely possible but imminent.

Poliomyelitis spreads through direct contact with an infected person's feces or respiratory secretions. It can strike both children and adults, and in its most severe form, it causes paralysis that can be permanent or fatal. The disease had been a scourge of childhood for generations before vaccines brought it under control. The fact that it had vanished from Brazil for more than three decades represented one of public health's great achievements—a victory that now seemed fragile.

The girl's case arrived amid a broader global resurgence. Cases had been confirmed in the United States and Israel, countries with far more robust healthcare infrastructure than many parts of Brazil. Physicians were sounding alarms: the conditions for polio's return were aligning. Vaccine hesitancy, misinformation, and logistical failures in reaching remote populations had created gaps in immunity that the virus could exploit. The girl in Rorainópolis, despite her seven vaccine doses, had become a symbol of that vulnerability.

Local authorities moved quickly. The municipal health office notified the state epidemiological surveillance team on August 29, the same day the case was reported. The state health secretariat confirmed that all cases of acute flaccid paralysis in children under fifteen must be investigated as part of Brazil's routine monitoring for poliovirus circulation. The investigation would determine whether this was indeed polio or another cause of paralysis. But the uncertainty itself was the point: Brazil had grown unaccustomed to asking that question. The machinery for detecting and responding to polio had atrophied along with the disease itself.

Health officials urged families to seek vaccination at their nearest basic health unit. The vaccine remained available for all children aged one to four. But availability and uptake are not the same thing. The collapse in coverage suggested that millions of Brazilian families were either unaware of the vaccine's importance, unable to access it, or actively choosing not to vaccinate their children. As investigators worked to confirm the diagnosis in Boa Vista, the larger crisis—the one that had allowed this case to emerge in the first place—remained unresolved.